The second issue of this program on the role of immune checkpoint inhibitors in the treatment of metastatic NSCLC without targetable alterations features a discussion with Dr Corey Langer, moderated by Dr Neil Love.

Oncology Today with Dr Neil Love: Role of Immune Checkpoint Inhibitors in the Management of Metastatic NSCLC without Actionable Mutations

Featuring one-on-one interviews conducted by Dr Neil Love, this series bridges the gap between research and patient care by providing medical oncologists, hematologists and hematology/oncology fellows ongoing access to the perspectives and opinions of national and international research leaders with an expertise in thoracic oncology.

Share Oncology Today with Dr Neil Love: Role of Immune Checkpoint Inhibitors in the Management of Metastatic NSCLC without Actionable Mutations

Sign up to save your podcasts

Oncology Today with Dr Neil Love: Role of Immune Checkpoint Inhibitors in the Management of Metastatic NSCLC without Actionable Mutations

Oncology Today with Dr Neil Love: Role of Immune Checkpoint Inhibitors in the Management of Metastatic NSCLC without Actionable Mutations

More shows like Lung Cancer Update

Gastrointestinal Cancer Update

Prostate Cancer Update

Breast Cancer Update

Gynecologic Oncology Update

Hematologic Oncology Update

Dermatologic Oncology Update

Lung Cancer CancerCare Connect Education Workshops

NEJM This Week

Journal of Clinical Oncology (JCO) Podcast

Research To Practice | Oncology Videos

ASCO Daily News

The Long Run with Luke Timmerman

ASCO Guidelines

Lung Cancer Considered

Oncology Today with Dr Neil Love

Business Of Biotech

Two Onc Docs